Advertisement Advertisement
U.S. Pharmacist Vaccine
Advertisement
U.S. Pharmacist PTA
December 2017

Pneumonia Vaccination Rates Low for Work-Related Asthma
Adults with work-related asthma have more severe symptoms and are at greater risk of developing pneumonia. Yet, according to a new study, only about half of them have received the pneumococcal polysaccharide vaccine. Although their vaccine rates are considerably higher than in patients with nonwork-related asthma, public health officials insist the rates still are too low. Here are the details.

Shingles Booster Better for Older Americans?
The herpes zoster vaccine used in the United States for the last 10 years begins to wane in effectiveness at 5 years, leaving its protection level especially questionable by 10 years, according to public health officials. Yet, official policy calls only for a single dose of the live attenuated herpes zoster vaccine. A new review looks at the cost-effectiveness in both dollars and quality of life in providing a booster to older Americans. When was the booster most cost-effective? Read more.

Vaccine Effective Against Common Meningococcal Strains
Neisseria meningitidis is responsible for a global annual disease burden of about 50,000 deaths and a similar number of long-term disabilities. It is now the most common cause of bacterial meningitis in children and young adults worldwide. In the United States, serogroup B strains cause approximately 30% of disease in all age groups. That's why testing showing high efficacy for a four-component vaccine is considered so significant. Based on those predictions, what percentage of bacterial strains causing serogroup B meningococcal disease would be covered by the vaccine? Find out more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App